These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 38118007)
1. Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening. Joh HS; Yeats C; Shaw A; Poudyal N; Gallagher P; Kim JH; Shaikh A; Seo HJ; Chi KK; Prifti K; Cho A; Sujan MJ; Eraly E; Pham KD; Shrestha S; Aboushady AT; Pak G; Jang G; Park EL; Seo HW; Abudahab K; Taylor BEW; Clark A; Dolabella B; Yoon H; Han J; Kwon SY; Marks F; Stelling J; Aanensen DM; MacWright WR; Holm M Clin Infect Dis; 2023 Dec; 77(Suppl 7):S507-S518. PubMed ID: 38118007 [TBL] [Abstract][Full Text] [Related]
2. CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual). Joh HS; Dolabella B; Early E; Stelling J; Ak G; Upadhyaya MK; Rahman A; Chuki P; MacWright WR; Ondoa P; Sarkar S; Moore C; Holm M; Leslie T; Zellweger RM; Paing G; Kwon SY; Marks F; Poudyal N Clin Infect Dis; 2023 Dec; 77(Suppl 7):S536-S542. PubMed ID: 38118006 [TBL] [Abstract][Full Text] [Related]
3. Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA). Holm M; MacWright WR; Poudyal N; Shaw AG; Joh HS; Gallagher PF; Kim JH; Shaikh AT; Seo HJ; Kwon SY; Prifti K; Dolabella B; Taylor BEW; Yeats C; Aanensen DM; Stelling J; Marks F Clin Infect Dis; 2023 Dec; 77(Suppl 7):S500-S506. PubMed ID: 38118015 [TBL] [Abstract][Full Text] [Related]
4. Effective Stakeholder Engagement for Collation, Analysis and Expansion of Antimicrobial Resistance (AMR) Data: A CAPTURA Experience. Poudyal N; Holm M; Joh HS; Gautam S; Sujan MJ; Kwon SY; Sahikh A; Shaw A; Gallagher P; Prifti K; Cho A; Chi KK; Aboushady AT; MacWright WR; Stelling J; Marks F Clin Infect Dis; 2023 Dec; 77(Suppl 7):S519-S527. PubMed ID: 38118005 [TBL] [Abstract][Full Text] [Related]
5. Recording and Reporting of Antimicrobial Resistance (AMR) Priority Variables and Its Implication on Expanding Surveillance Sites in Nepal: A CAPTURA Experience. Maharjan S; Gallagher P; Gautam M; Joh HS; Sujan MJ; Aboushady AT; Kwon SY; Gautam S; Upadhyaya MK; Jha R; Acharya J; MacWright WR; Marks F; Stelling J; Poudyal N Clin Infect Dis; 2023 Dec; 77(Suppl 7):S560-S568. PubMed ID: 38118014 [TBL] [Abstract][Full Text] [Related]
6. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia. Malania L; Wagenaar I; Karatuna O; Tambic Andrasevic A; Tsereteli D; Baidauri M; Imnadze P; Nahrgang S; Ruesen C Clin Microbiol Infect; 2021 Oct; 27(10):1409-1413. PubMed ID: 34044149 [TBL] [Abstract][Full Text] [Related]
7. Key Recommendations for Antimicrobial Resistance Surveillance: Takeaways From the CAPTURA Project. Aboushady AT; Sujan MJ; Pham K; Clark A; Marks F; Holm M; Joh HS; Poudyal N; Stelling J Clin Infect Dis; 2023 Dec; 77(Suppl 7):S581-S587. PubMed ID: 38118016 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Resistance Surveillance Methods in Bangladesh: Present and Way Forward. Sujan MJ; Habib ZH; Rahman A; Rizvi SMS; Barua HT; Aboushady AT; Hasnat MA; Rasul SBG; Joh HS; Prifti K; Chi KK; Kwon SY; Clark A; Gautam S; Holm M; Marks F; Stelling J; Shaw A; Poudyal N Clin Infect Dis; 2023 Dec; 77(Suppl 7):S549-S559. PubMed ID: 38118018 [TBL] [Abstract][Full Text] [Related]
9. The Reality of Antimicrobial Resistance and Antibiotic Usage Data in Asia: The CAPTURA Experience. Leslie T; Parry C; Ondoa P; Walsh T; Moore C; Poudyal N; Marks F; Gordon NC Clin Infect Dis; 2023 Dec; 77(Suppl 7):S497-S499. PubMed ID: 38118008 [TBL] [Abstract][Full Text] [Related]
11. Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries. Lim C; Ashley EA; Hamers RL; Turner P; Kesteman T; Akech S; Corso A; Mayxay M; Okeke IN; Limmathurotsakul D; van Doorn HR Clin Microbiol Infect; 2021 Oct; 27(10):1391-1399. PubMed ID: 34111583 [TBL] [Abstract][Full Text] [Related]
12. Utility and Evaluation of Applied Project Management Processes Within a Large Multicountry Health Systems Development Project Conducted During the Coronavirus Disease 2019 (COVID-19) Pandemic. Kwon SY; Gautam S; Poudel K; Banneheke H; Ferreira D; Gautam M; Hau'ofa M; Mahmood N; Phommalad B; Sujan MJ; Yangzom P; Joh HS; Shaw A; Dolabella B; Seo HJ; Kim JH; Gallagher P; MacWright WR; Poudyal N; Marks F; Holm M Clin Infect Dis; 2023 Dec; 77(Suppl 7):S543-S548. PubMed ID: 38118010 [TBL] [Abstract][Full Text] [Related]
13. How a laboratory-based antimicrobial resistance (AMR) regional surveillance system can address large-scale and local AMR epidemiology: the MICRO-BIO experience. Comelli A; Zanforlini M; Mazzone A; Pedroni P; De Castro U; Scarioni S; D'Amelio AC; Renisi G; Bandera A; Gori A; Schiatti S; Cereda D; Front Public Health; 2024; 12():1341482. PubMed ID: 38410663 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries. Gandra S; Alvarez-Uria G; Turner P; Joshi J; Limmathurotsakul D; van Doorn HR Clin Microbiol Rev; 2020 Sep; 33(3):. PubMed ID: 32522747 [TBL] [Abstract][Full Text] [Related]
15. Exploring the factors that contribute to the successful implementation of antimicrobial resistance interventions: a comparison of high-income and low-middle-income countries. Graells T; Lambraki IA; Cousins M; Léger A; Henriksson PJG; Troell M; Carson CA; Parmley EJ; Majowicz SE; Wernli D; Jørgensen PS Front Public Health; 2023; 11():1230848. PubMed ID: 37900049 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance in low- and middle-income countries: current status and future directions. Sulis G; Sayood S; Gandra S Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545 [TBL] [Abstract][Full Text] [Related]
17. Train-the-Trainer as an Effective Approach to Building Global Networks of Experts in Genomic Surveillance of Antimicrobial Resistance (AMR). Abrudan M; Matimba A; Nikolic D; Hughes D; Argimón S; Kekre M; Underwood A; Aanensen DM; Clin Infect Dis; 2021 Dec; 73(Suppl_4):S283-S289. PubMed ID: 34850831 [TBL] [Abstract][Full Text] [Related]
18. Development of a cross-sectoral antimicrobial resistance capability assessment framework. Ferdinand AS; McEwan C; Lin C; Betham K; Kandan K; Tamolsaian G; Pugeva B; McKenzie J; Browning G; Gilkerson J; Coppo M; James R; Peel T; Levy S; Townell N; Jenney A; Stewardson A; Cameron D; Macintyre A; Buising K; Howden BP BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232993 [TBL] [Abstract][Full Text] [Related]
19. The barriers and facilitators of implementing a national laboratory-based AMR surveillance system in Cambodia: key informants' perspectives and assessments of microbiology laboratories. Mao S; Soputhy C; Lay S; Jacobs J; Ku GM; Chau D; Chhea C; Ir P Front Public Health; 2023; 11():1332423. PubMed ID: 38179556 [TBL] [Abstract][Full Text] [Related]
20. Surveillance of antimicrobial resistance in the United Arab Emirates: the early implementation phase. Thomsen J; Abdulrazzaq NM; AlRand H; Front Public Health; 2023; 11():1247627. PubMed ID: 38074700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]